Immunexpress is a molecular diagnostic company focused on improving outcomes for suspected sepsis patients. In this interview CEO Dr. Rollie Carlson discusses the company’s FDA-cleared sepsis diagnostic test and the value it brings to the healthcare system. Please describe the story behind the company: What sparked the idea, and how has it evolved so far?

Never before have our innovators and entrepreneurs had as much opportunity as they do today.  The days of leaving Tampa Bay to be successful are over.  Our community is ready and willing to fund great ideas. Venture Catalyst connects investors, mentors and supporting organizations with the startups that will grow here and prosper here. This […]

In late January 2020, I attended the American Society for Microbiology annual biothreats conference. The plenary session with Dr. Anthony Fauci turned out to be his first public remarks on the novel coronavirus (nCoV2019), soon known as COVID-19. Most people in the room, some of us veterans of the war on HIV, understood there was a brutal […]